Of these, 627 patients who showed a suboptimal response after 8 weeks of treatment with olmesartan medoxomil 20 mg/day were randomised to receive olmesartan medoxomil 40 mg/day (n = 302 ...
In this study, olmesartan 20 mg/day was found to be more potent and brought about a faster BP reduction than losartan 50 mg/day. These findings may be a useful reference for clinicians prescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback